LEGN logo

Legend Biotech (LEGN) EBIT

annual EBIT:

-$136.52M+$361.81M(+72.60%)
December 31, 2024

Summary

  • As of today (June 29, 2025), LEGN annual earnings before interest & taxes is -$136.52 million, with the most recent change of +$361.81 million (+72.60%) on December 31, 2024.
  • During the last 3 years, LEGN annual EBIT has risen by +$269.78 million (+66.40%).
  • LEGN annual EBIT is now -8799.48% below its all-time high of -$1.53 million, reached on December 31, 2018.

Performance

LEGN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

quarterly EBIT:

-$94.07M-$139.73M(-306.01%)
March 31, 2025

Summary

  • As of today (June 29, 2025), LEGN quarterly earnings before interest & taxes is -$94.07 million, with the most recent change of -$139.73 million (-306.01%) on March 31, 2025.
  • Over the past year, LEGN quarterly EBIT has dropped by -$39.76 million (-73.20%).
  • LEGN quarterly EBIT is now -306.01% below its all-time high of $45.66 million, reached on December 31, 2024.

Performance

LEGN quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

TTM EBIT:

-$176.27M-$39.76M(-29.12%)
March 31, 2025

Summary

  • As of today (June 29, 2025), LEGN TTM earnings before interest & taxes is -$176.27 million, with the most recent change of -$39.76 million (-29.12%) on March 31, 2025.
  • Over the past year, LEGN TTM EBIT has increased by +$269.50 million (+60.46%).
  • LEGN TTM EBIT is now -1322.48% below its all-time high of -$12.39 million, reached on March 31, 2019.

Performance

LEGN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LEGN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+72.6%-73.2%+60.5%
3 y3 years+66.4%-202.7%+48.6%
5 y5 years-4.9%-114.1%-9.0%

LEGN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+72.6%-306.0%+51.4%-29.1%+65.6%
5 y5-year-4.9%+72.6%-306.0%+51.4%-29.1%+65.6%
alltimeall time-8799.5%+72.6%-306.0%+51.4%-1322.5%+65.6%

LEGN EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$94.07M(-306.0%)
-$176.27M(+29.1%)
Dec 2024
-$136.52M(-72.6%)
$45.66M(-139.6%)
-$136.52M(-57.8%)
Sep 2024
-
-$115.38M(+824.1%)
-$323.17M(+22.1%)
Jun 2024
-
-$12.49M(-77.0%)
-$264.61M(-40.6%)
Mar 2024
-
-$54.31M(-61.5%)
-$445.78M(-10.5%)
Dec 2023
-$498.32M(+14.6%)
-$140.99M(+148.1%)
-$498.32M(+2.1%)
Sep 2023
-
-$56.82M(-70.7%)
-$488.19M(-4.8%)
Jun 2023
-
-$193.65M(+81.2%)
-$512.93M(+0.4%)
Mar 2023
-
-$106.86M(-18.3%)
-$510.71M(+17.4%)
Dec 2022
-$434.93M(+7.0%)
-$130.86M(+60.5%)
-$434.93M(+5.4%)
Sep 2022
-
-$81.56M(-57.4%)
-$412.79M(-9.6%)
Jun 2022
-
-$191.43M(+515.9%)
-$456.41M(+33.1%)
Mar 2022
-
-$31.08M(-71.4%)
-$342.81M(-15.6%)
DateAnnualQuarterlyTTM
Dec 2021
-$406.30M(+31.9%)
-$108.72M(-13.2%)
-$406.30M(+12.9%)
Sep 2021
-
-$125.18M(+60.8%)
-$359.97M(+19.3%)
Jun 2021
-
-$77.83M(-17.7%)
-$301.75M(-15.9%)
Mar 2021
-
-$94.56M(+51.6%)
-$358.71M(+16.4%)
Dec 2020
-$308.09M(+136.7%)
-$62.39M(-6.8%)
-$308.09M(+0.3%)
Sep 2020
-
-$66.96M(-50.3%)
-$307.30M(+14.6%)
Jun 2020
-
-$134.79M(+206.7%)
-$268.04M(+65.8%)
Mar 2020
-
-$43.95M(-28.7%)
-$161.70M(+24.2%)
Dec 2019
-$130.15M(+8384.2%)
-$61.60M(+122.3%)
-$130.15M(+89.9%)
Sep 2019
-
-$27.71M(-2.6%)
-$68.55M(+67.9%)
Jun 2019
-
-$28.45M(+129.6%)
-$40.84M(+229.6%)
Mar 2019
-
-$12.39M
-$12.39M
Dec 2018
-$1.53M
-
-

FAQ

  • What is Legend Biotech annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Legend Biotech?
  • What is Legend Biotech annual EBIT year-on-year change?
  • What is Legend Biotech quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Legend Biotech?
  • What is Legend Biotech quarterly EBIT year-on-year change?
  • What is Legend Biotech TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Legend Biotech?
  • What is Legend Biotech TTM EBIT year-on-year change?

What is Legend Biotech annual earnings before interest & taxes?

The current annual EBIT of LEGN is -$136.52M

What is the all time high annual EBIT for Legend Biotech?

Legend Biotech all-time high annual earnings before interest & taxes is -$1.53M

What is Legend Biotech annual EBIT year-on-year change?

Over the past year, LEGN annual earnings before interest & taxes has changed by +$361.81M (+72.60%)

What is Legend Biotech quarterly earnings before interest & taxes?

The current quarterly EBIT of LEGN is -$94.07M

What is the all time high quarterly EBIT for Legend Biotech?

Legend Biotech all-time high quarterly earnings before interest & taxes is $45.66M

What is Legend Biotech quarterly EBIT year-on-year change?

Over the past year, LEGN quarterly earnings before interest & taxes has changed by -$39.76M (-73.20%)

What is Legend Biotech TTM earnings before interest & taxes?

The current TTM EBIT of LEGN is -$176.27M

What is the all time high TTM EBIT for Legend Biotech?

Legend Biotech all-time high TTM earnings before interest & taxes is -$12.39M

What is Legend Biotech TTM EBIT year-on-year change?

Over the past year, LEGN TTM earnings before interest & taxes has changed by +$269.50M (+60.46%)
On this page